Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Cholecystokinin Receptor
    (4)
  • Others
    (5)
Filter
Search Result
Results for "

cholecystokinin 1 receptor

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    9
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Natural Products
    1
    TargetMol | Natural_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
GI 181771
T15382305366-98-7
GI 181771 is an agonist of the cholecystokinin 1 receptor. GI 181771 can be used in studies about obesity.
  • $195
In Stock
Size
QTY
Ceruletide
FI-6934, Cerulein, Caerulein
T1493217650-98-5
Ceruletide is a decapeptide that serves as a safe and effective cholecystokinin receptor agonist, exerting a direct spasmogenic effect on the gallbladder muscle and bile ducts, and is commonly used to establish pancreatitis models.
  • $33
In Stock
Size
QTY
TargetMol | Inhibitor Hot
CCK-A receptor inhibitor 1
T12404137004-80-9In house
CCK-A receptor inhibitor 1 is a potent cholecystokinin A (CCK-A) receptor inhibitor (IC50: 340 nM) and can be used to study digestive system-related diseases.
  • $700
In Stock
Size
QTY
CCK-B Receptor Antagonist 1
T13261168161-71-5
CCK-B Receptor Antagonist 1 is a cholecystokinin B (CCK-B) receptor agonist and has the potential of reducing the secretion of gastric acid.
  • $45
5 days
Size
QTY
SR 146131
T16935221671-61-0
SR 146131 is a potent and selective agonist of the nonpeptide receptor.
    7-10 days
    Inquiry
    ZP3022
    T2077951345835-12-2
    ZP3022 is a dual agonist targeting the glucagon-like peptide 1 receptor (GLP-1R) and cholecystokinin 2 (CCK2) receptor. It selectively enhances cAMP accumulation or ERK phosphorylation in HEK293 cells with GLP-1R or CCK2 receptor expression, compared to ERK phosphorylation in cells with the CCK1 receptor (EC50s: 0.02, 10.3, and >1,000 nM for human receptors, respectively). At 40 nM, ZP3022 promotes proliferation of rat neonatal β-cells in vitro. It also boosts glucose-induced insulin secretion (GSIS) in rat pancreatic islets at 10 and 100 nM concentrations and decreases body weight in rats at 40 nmol/kg doses twice daily. Administered at 100 nmol/kg daily, ZP3022 enhances β-cell and total pancreatic mass and improves glucose tolerance in db/db mice, while reducing food intake but not body weight in these mice.
    • Inquiry Price
    Size
    QTY
    Loxiglumide
    CR-1505
    T2312107097-80-3
    Loxiglumide (CR-1505) is an antagonist of cholecystokinin (CCK-1) receptor.
    • $34
    In Stock
    Size
    QTY
    JNJ-17156516
    JNJ17156516,JNJ 17156516
    T27664649551-06-4
    JNJ-17156516 is a potent, and selective cholecystokinin 1 receptor antagonist.
    • $1,520
    6-8 weeks
    Size
    QTY
    CE-326597
    T68482870615-40-0
    CE-326597 is a potent and selective CCK1R agonist. The type 1 cholecystokinin receptor (CCK1R) has multiple physiologic roles relating to nutrient homeostasis,including mediation of postcibal satiety. The type 1 cholecystokinin (CCK) receptor (CCK1R) is a key mediator of postcibal satiety and a potential target for drugs that may be useful to prevent and or treat obesity.
    • $1,520
    6-8 weeks
    Size
    QTY